pharma · Migraine · Narcolepsy
H. Lundbeck A/S
H. Lundbeck A/S is a pharma organization headquartered in Valby, CN. Primary therapeutic focus areas include Migraine, Narcolepsy, Schizophrenia, Multiple System Atrophy, Chronic Migrane, Migrane, Medication Overuse Head
Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN HQ
112 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Postboks 361, LYSAKER, Bærum 1326, NO, Valby, CN
- Employees
- 112
- Programs
- 17
- Drugs
- 14
- Patents
- 0
VYEPTI 100 mg concentrate for solution for infusion
Approved · small molecule · Chronic Migrane, Migrane, Medication Overuse Headache
VYEPTI 100 mg concentrate for solution for infusion for Chronic Migrane, Migrane, Medication Overuse Headache is a Approved program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).
Internal code RESOLUTION 20007A
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- H. Lundbeck A/S
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Chronic Migrane, Migrane, Medication Overuse Headache
- Status
- active
- Trials
- 1